A Phase II Randomized, Double-Blind, Placebo Controlled Study of the Clinical Effectiveness of a Human Monoclonal Antibody to Clostridium difficile Toxin A [GS-CDA1] and a Human Monoclonal Antibody to

Grants and Contracts Details

Description

none available
StatusFinished
Effective start/end date10/1/073/31/13

Funding

  • University of Massachusetts: $11,161.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.